ACP
BDSI

Acuta Capital Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Acuta Capital Partners’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-212,100
Closed -$1.18M – 81
2015
Q3 		$1.18M Buy
+212,100
New +$1.57M 0.68% 39

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Acuta Capital Partners's BDSI Position: Q4 2015 in Review

Acuta Capital Partners sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2015, closing a stake of 212,100 shares — an estimated $1.18M sold.

Acuta Capital Partners first reported a position in BDSI in Q3 2015 and held it in 1 quarter. The position peaked at $1.18M in Q3 2015. 126 funds tracked by Wall St. Rank hold BDSI as of Q4 2015.

  • Acuta Capital Partners reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2015 after selling out during the quarter.
  • Acuta Capital Partners sold 212,100 BioDelivery Sciences International, Inc. shares in Q4 2015, an estimated $1.18M.
  • Acuta Capital Partners first reported a position in BioDelivery Sciences International, Inc. in Q3 2015 and held it in 1 quarter.
  • Acuta Capital Partners's BioDelivery Sciences International, Inc. position peaked at $1.18M in Q3 2015.
  • 126 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2015.

Based on Acuta Capital Partners's 13F filing for Q4 2015, filed 12 Feb 2016.